Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
disease | 0.700 | limited | 0.951 | 8 | 3 | 2005 | 2019 | ||||||||
|
C9orf72-SMCR8 complex subunit | 0.496 | 0.769 | 1.1E-06 |
|
disease | 0.800 | limited | 0.985 | 7 | 4 | 2009 | 2020 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.700 | limited | 1.000 | 7 | 2 | 2007 | 2020 | ||||||||
|
HtrA serine peptidase 1 | 0.532 | 0.692 | 4.9E-04 |
|
disease | 0.500 | limited | 0.940 | 5 | 3 | 2006 | 2019 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.700 | limited | 0.966 | 3 | 3 | 2006 | 2019 | ||||||||
|
paired box 4 | 0.644 | 0.423 | 4.2E-04 |
|
disease | 1.000 | limited | 0.857 | 2 | 1 | 1999 | 2019 | ||||||||
|
triggering receptor expressed on myeloid cells 2 | 0.519 | 0.769 | 3.3E-09 |
|
disease | 0.700 | limited | 0.977 | 2 | 2 | 2007 | 2020 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.680 | limited | 1.000 | 2 | 2 | 2006 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.800 | limited | 0.956 | 1 | 1 | 1996 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
disease | 0.800 | disputed | 0.929 | 1 | 1 | 1998 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 13 | 8 | 1998 | 2019 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
phenotype | 0.400 | moderate | 1.000 | 4 | 3 | 2010 | 2018 | ||||||||
|
filaggrin | 0.525 | 0.846 | 2.9E-04 |
|
disease | 0.700 | moderate | 0.961 | 1 | 1 | 2005 | 2020 | ||||||||
|
SH2B adaptor protein 1 | 0.566 | 0.731 | 0.97 |
|
disease | 0.700 | moderate | 0.906 | 1 | 1 | 2009 | 2020 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.900 | strong | 0.943 | 10 | 3 | 1996 | 2019 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
disease | 0.700 | strong | 0.974 | 6 | 4 | 2002 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.500 | strong | 0.969 | 5 | 4 | 2008 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.900 | strong | 0.954 | 3 | 4 | 1995 | 2019 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
group | 0.500 | strong | 1.000 | 2 | 1 | 2006 | 2020 | ||||||||
|
TANK binding kinase 1 | 0.513 | 0.846 | 7.5E-02 |
|
disease | 0.700 | strong | 1.000 | 2 | 1 | 2015 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
disease | 0.700 | strong | 1.000 | 2 | 1 | 2005 | 2019 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 1.000 | strong | 0.980 | 2 | 2 | 1988 | 2020 | ||||||||
|
serologically defined colon cancer antigen 8 | 0.619 | 0.577 | 1.2E-11 |
|
disease | 0.440 | strong | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.900 | strong | 0.915 | 1 | 1 | 1998 | 2020 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 0.900 | strong | 0.953 | 1 | 1 | 1992 | 2020 |